This information is for educational purposes only. It is not intended as medical advice. Always consult a qualified healthcare professional.
OLUMIANT 2 MG COMPRIMIDOS RECUBIERTOS CON PELICULA — Description, Dosage, Side Effects | PillsCard
OTC
OLUMIANT 2 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
INN: OLUMIANT
Data updated: 2026-04-11
Available in:
🇩🇪🇬🇧🇪🇸
Form
—
Dosage
—
Route
—
Storage
—
About This Product
Manufacturer
Eli Lilly Nederland B.V.
User Reviews
Reviews reflect personal experiences and are not medical advice. Always consult your doctor.
(ES)
Source
CIMA_ES
(
ARTG
)
Rheumatoid Arthritis,OLUMIANT is indicated for the treatment of moderate to severe active rheumatoid arthritis (RA) in adult patients who have responded inadequately, or who are intolerant, to one or more DMARDs.,OLUMIANT can be taken as monotherapy or in combination with cDMARDs, including methotrexate (MTX).,Atopic Dermatitis,OLUMIANT is indicated for the treatment of moderate to severe atopic dermatitis (AD) in adult patients who are candidates for systemic therapy.,Alopecia Areata,OLUMIANT is indicated for the treatment of severe alopecia areata (AA) in adult patients in whom other treatments have failed or are not appropriate and no spontaneous improvement is observed (see section 5.1 Pharmacodynamic properties; Clinical trials).
